Intramuscular ketamine vs. escitalopram and aripiprazole in acute and maintenance treatment of patients with treatment-resistant depression: A randomized double-blind clinical trial

OBJECTIVE: Ketamine, an N-methyl D-aspartate (NMDA) receptor antagonist, can promote rapid action in the management of individuals with treatment-resistant depression (TRD) at sub-anesthetic doses. However, few studies have investigated the long-term use of ketamine administered intravenously (IV) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cigognini, Marco Aurélio, Guirado, Alia Garrudo, van de Meene, Denise, Schneider, Mônica Andréia, Salomon, Mônica Sarah, de Alexandria, Vinicius Santana, Adriano, Juliana Pisseta, Thaler, Ana Maria, Fernandes, Fernando dos Santos, Carneiro, Adriana, Moreno, Ricardo Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354749/
https://www.ncbi.nlm.nih.gov/pubmed/35935445
http://dx.doi.org/10.3389/fpsyt.2022.830301

Ejemplares similares

Ejemplares similares